Silo Pharma Eulerpool News

Silo Pharma Stock News

Silo Pharma is being monitored by journalists and investors worldwide. We gather the latest Silo Pharma news here.

• July 7 ·

  Yahoo
  Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025
• June 27 ·

  Yahoo
  Psychedelic: Compass Pathways achieves primary endpoint in COMP360 trial
• June 25 ·

  Yahoo
  Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.
• June 16 ·

  Yahoo
  Weekly Roundup on the Cannabis Sector & Psychedelic Sector
• June 11 ·

  Yahoo
  Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears
• February 11 ·

  Yahoo
  Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and Fibromyalgia
• January 22 ·

  Yahoo
  Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD Treatment
• January 9 ·

  Yahoo
  Silo Pharma awarded U.S. patent for PTSD treatment
• January 8 ·

  Yahoo
  Silo Pharma Awarded US Patent for Groundbreaking PTSD Treatment and Prepares for SPC-15 Clinical Trial
• January 2 ·

  Yahoo
  Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain